Share on StockTwits

CombiMatrix (NASDAQ:CBMX) CFO Scott R. Burell acquired 1,000 shares of CombiMatrix stock in a transaction that occurred on Wednesday, August 27th. The stock was purchased at an average cost of $2.04 per share, with a total value of $2,040.00. Following the completion of the purchase, the chief financial officer now directly owns 1,912 shares of the company’s stock, valued at approximately $3,900. The transaction was disclosed in a filing with the SEC, which is available at this link.

Shares of CombiMatrix (NASDAQ:CBMX) traded down 3.90% during mid-day trading on Thursday, hitting $1.97. The stock had a trading volume of 167,793 shares. CombiMatrix has a 52-week low of $1.91 and a 52-week high of $4.44. The stock has a 50-day moving average of $2.16 and a 200-day moving average of $2.49. The company’s market cap is $21.8 million.

Separately, analysts at Zacks reiterated an “outperform” rating on shares of CombiMatrix in a research note on Friday, August 8th. They now have a $3.50 price target on the stock.

CombiMatrix Corporation is a molecular diagnostics company. The Company operates in the field of genetic analysis and molecular diagnostics through its wholly owned subsidiary, CombiMatrix Molecular Diagnostics, Inc located in Irvine, California.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.